Sanofi is a Sponsor of no-charge genetic testing programs for patients suspected of having familial arrhythmia or cardiomyopathy, or a muscular dystrophy.

Genetic testing is provided by Invitae, who offers comprehensive genetic panel testing programs across different therapeutic areas.

Genetic panel testing programs improve diagnosis, risk stratification, and disease management.

  • Detect Cardiomyopathy and Arrhythmia:
    The Invitae Cardiomyopathy and Arrhythmia Comprehensive Panel tests up to 168 genes associated with inherited arrhythmia and cardiomyopathy conditions.
    Login/Register to learn more

  • Detect Muscular Dystrophy:
    The Invitae Detect genetic testing program offers six panel options that test for variants in genes associated with muscular dystrophies.
    Login/Register to learn more

LOGIN/REGISTER for more information

Discover full details about Detect genetic panel testing programs, including how to order a kit.